User menu

Atherosclerosis and Cerebral Ischemic Attacks - Intakes of Cerebrography With Xe-133 Inhaled and Platelet Tests in the Diagnosis, Clinical and Therapeutic Monitoring - the Preventive Role of Dipyridamole

Bibliographic reference Solvay, H. ; Kahn, M. ; Selosse, P. ; Carlier, J. ; Cloarec, M. ; et. al. Atherosclerosis and Cerebral Ischemic Attacks - Intakes of Cerebrography With Xe-133 Inhaled and Platelet Tests in the Diagnosis, Clinical and Therapeutic Monitoring - the Preventive Role of Dipyridamole. In: Angiology, Vol. 35, no. 11, p. 709-718 (1984)
Permanent URL http://hdl.handle.net/2078.1/55764
  1. Cooper BS, Social Security Bulletin (1976)
  2. Wolf PA: HTA as a risk factor for stroke. In: Cerebral vascular diseases-Winter conference. Ed. by Whisnant JP, Sandok BA. Furne and Stratton Inc, New York, 1974 , pp. 105-112.
  3. Barnett Hjm, Med Clin North Amer, 63, 4 (1979)
  4. Harker LA, Circulation, 62, 13 (1980)
  5. Genton E., Barnett H. J., Fields W. S., Gent M., Hoak J. C., XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy, 10.1161/01.str.8.1.150
  6. Charlier R.: Antianginal drugs. Springer-Verlag Berlin 108-109, 1971.
  7. Solvay H., Evaluation du rapport dose/réponse au dipyridamole. Acta Therapeutica, 7, 275 (1981)
  8. Solvay H., Ars Medici, 36, 8 (1981)
  9. Jørgensen Kaj Anker, Dyerberg Jørn, Stoffersen Erik, Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation, 10.1016/s0031-6989(79)80032-6